Table 1.

Cell-cycle analysis of human Burkitt B-lymphoma cells treated with SP600125 inhibitor for 48 hours


Cell line

Sub-G1 (apoptotic)

G0/G1

S

G2/M
BJAB (medium)   1 ± 0   42 ± 0   25 ± 0   32 ± 0  
BJAB (SP600125, 20 μM)   3 ± 0   18 ± 1   15 ± 1   64 ± 2  
RAJI (medium)   6 ± 1   39 ± 0   38 ± 1   16 ± 0  
RAJI (SP600125, 20 μM)
 
13 ± 1
 
22 ± 1
 
30 ± 2
 
33 ± 2
 

Cell line

Sub-G1 (apoptotic)

G0/G1

S

G2/M
BJAB (medium)   1 ± 0   42 ± 0   25 ± 0   32 ± 0  
BJAB (SP600125, 20 μM)   3 ± 0   18 ± 1   15 ± 1   64 ± 2  
RAJI (medium)   6 ± 1   39 ± 0   38 ± 1   16 ± 0  
RAJI (SP600125, 20 μM)
 
13 ± 1
 
22 ± 1
 
30 ± 2
 
33 ± 2
 

Values presented are percentage of cells in each phase of cell cycle. Phase of cell cycle was determined by flow cytometric analysis of propidium iodide-stained cells. Results are presented as means ± SE of triplicate cultures. Experiments were performed 2 to 3 times with similar outcome.

or Create an Account

Close Modal
Close Modal